Log In
Print this Print this

Apligraf (formerly CelTx, Graftskin)

  Manage Alerts
Collapse Summary General Information
Company Organogenesis Inc.
DescriptionEngineered tissue with layers of keratinocytes and fibroblasts
Molecular Target Not available
Mechanism of ActionCell therapy
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentMarketed
Standard IndicationDermal ulcers
Indication DetailsTreat chronic venous ulcers; Treat decubitus ulcers (pressure sores); Treat diabetic foot ulcers; Treat diabetic foot ulcers and venous leg ulcers; Treat venous leg ulcers; Treat venous stasis ulcers
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today